CAS: 18550-98-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (E)-3PO REF: IN-DA00AQDHCAS: 18550-98-6 | 99% | To inquire | Mon 13 Jan 25 |
 | 3PO REF: TM-T22223CAS: 18550-98-6 | 97.76% - 99.67% | 56.00 €~794.00 € | Tue 21 Jan 25 |
 | 3PO REF: 3D-TAA55098CAS: 18550-98-6 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00AQDH
| 1g | 159.00 € | ||
| 5g | 520.00 € | ||
| 100mg | 60.00 € | ||
| 250mg | 102.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
3PO
CAS:18550-98-6
3PO inhibits PFKFB3 (IC50: 22.9 µM) and cancer cell growth (IC50: 1.4-24 µM), reducing glucose …
Formula:
C13H10N2O
Purity:
97.76% - 99.67%
Color and Shape:
Solid
Molecular weight:
210.23
Ref: TM-T22223
| 5mg | 56.00 € | ||
| 10mg | 80.00 € | ||
| 25mg | 124.00 € | ||
| 50mg | 184.00 € | ||
| 100mg | 333.00 € | ||
| 200mg | 495.00 € | ||
| 500mg | 794.00 € | ||
| 1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
3PO
CAS:18550-98-6
3PO is a compound that is synthesized from an inorganic acid and has shown to …
Formula:
C13H10N2O
Purity:
Min. 95%
Molecular weight:
210.23 g/mol
Ref: 3D-TAA55098
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
